- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01998490
Animal-assisted or Robot-assisted Interventions in Health Promotion for Elderly With Dementia
Animal-assisted or Robot-assisted Interventions in Health Promotion for Elderly With Dementia: Impact on Factors Related to the Risk of Falls, on Evidence Based Practice and on the Relatives' Burden
The overall research aim of this study is to investigate changes in measures related to the risk of falls among elderly with dementia participating in animal-assisted or robot-assisted interventions. In addition the study will investigate how knowledge transfer occurs among involved health personnel, and how knowledge is refined and transformed as practical competence. The design will be a prospective and cluster randomized multicenter trial, but mixed-methods will be used to target different outcomes. The study population will be elderly (age above 65) at nursing homes diagnosed with dementia, or having a cognitive deficit. The intervention will consist of 30 minutes sessions with animal-assisted activity or robot-assisted activity two times a week for 12 weeks in groups of 4-6 participants. Control groups will receive treatment as usual. Research questions:
- Is there an effect in use of ordinary and optional medication among elderly persons with dementia at nursing homes participating in animal-assisted or robot-assisted interventions compared to a control group?
- Is there an effect on agitation, restlessness and depression among elderly persons with dementia at nursing homes participating in animal-assisted or robot-assisted interventions compared to a control group?
- Is there an effect on social interaction, activeness and wellbeing among elderly persons with dementia at nursing homes participating in animal-assisted or robot-assisted interventions compared to a control group?
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Fet, Norway
- Pålsetunet bo- og servicesenter
-
Fredrikstad, Norway
- Solliheimen Sykehjem
-
Halden, Norway
- Solheimen senter
-
Larvik, Norway
- Frida Sykehjem
-
Lørenskog, Norway
- Lørenskog Sykehjem, avd. Losbyveien
-
Lørenskog, Norway
- Løreskog sykhjem, avd Krydderhagen
-
Moss, Norway
- Orkerød Sykehjem
-
Moss, Norway
- Ryggeheimen
-
Nøtterøy, Norway
- Gipø Sykehjem
-
Oppegård, Norway
- Greverud Sykehjem
-
Oppegård, Norway
- Høyås Sykehjem
-
Sande, Norway
- Sandetun Sykehjem
-
Sandefjord, Norway
- Kamfjordhjemmet
-
Sørum, Norway
- Sørvald bo- og behandlingssenter
-
Tjøme, Norway
- Tjøme Sykehjem
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of dementia or having a cognitive deficit measured as a score less than 25 on Mini-Mental State Examination.
Exclusion Criteria:
- Fear of dogs
- Dog allergy
- Need of wheel chair
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Animal-assisted activity
30 minutes group session with animal-assisted activity twice a week for 12 weeks in groups of 4-6 participants.
|
|
No Intervention: Control
Control group with treatment as usual
|
|
Experimental: Robot-assisted activity
30 minutes group session with robot-assisted activity with the robot seal Paro twice a week for 12 weeks in groups of 4-6 participants
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Norwegian version of The Brief Agitation Rating Scale
Time Frame: Second last or last week before the intervention starts, after 4 and 8 weeks of the intervention, and first or second week after end of intervention. A follow-up measure 3 months after end of the intervention
|
Second last or last week before the intervention starts, after 4 and 8 weeks of the intervention, and first or second week after end of intervention. A follow-up measure 3 months after end of the intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Norwegian version of Cornell scale for depression
Time Frame: Second last or last week before the intervention starts, after 4 and 8 weeks of the intervention, and first or second week after end of intervention. A follow-up measure 3 months after end of the intervention
|
Second last or last week before the intervention starts, after 4 and 8 weeks of the intervention, and first or second week after end of intervention. A follow-up measure 3 months after end of the intervention
|
|
Change in Norwegian version of QUALID
Time Frame: Second last og last week before the intervention starts, after 6 weeks of the intervention, and first or second week after end of intervention. A follow-up measure 3 months after end of the intervention
|
Second last og last week before the intervention starts, after 6 weeks of the intervention, and first or second week after end of intervention. A follow-up measure 3 months after end of the intervention
|
|
Change in behaviours, engagement and well-being measured by use of Dementia Care Mapping
Time Frame: Second last or last week before the intervention starts, after 6 weeks of the intervention, and first or second week after end of intervention.
|
Second last or last week before the intervention starts, after 6 weeks of the intervention, and first or second week after end of intervention.
|
|
Change in physical activity measured by use of Actigraphy
Time Frame: Second last or last week before the intervention starts, after 6 weeks of the intervention, and first or second week after end of intervention
|
A device worn by the participants for one week at each time point of measure, night and day, measuring physical movement.
|
Second last or last week before the intervention starts, after 6 weeks of the intervention, and first or second week after end of intervention
|
Video recordings
Time Frame: After two and ten weeks of the interventions
|
The video recorded will be analyzed with respect to social interaction and group dynamics
|
After two and ten weeks of the interventions
|
Change in use of ordinary and optional medication
Time Frame: Second last or last week before the intervention starts, first or second week after end of intervention and 3 months after end of intervention
|
Second last or last week before the intervention starts, first or second week after end of intervention and 3 months after end of intervention
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Camilla Ihlebæk, PhD, Norwegian University of Life Sciences
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012/1144
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden
Clinical Trials on Animal-assisted activity
-
Norwegian University of Life SciencesCompleted
-
Atlas UniversityNot yet recruitingDepression | Loneliness | Old Age; Debility | Nursing Home | Loss of Interest in Activities
-
Swiss Tropical & Public Health InstituteRehab Basel; University of BaselCompletedBrain Injuries | Consciousness DisorderSwitzerland
-
Washington State UniversityCompletedStress, Psychological | Stress, Physiological
-
University of Colorado, DenverPurdue University; Human Animal Bond Institute for ResearchCompletedAutism Spectrum Disorder | Child Behavior | Psychiatric Hospitalization | Veterinary Therapeutics
-
Şeyma DemiralayCompletedStress | Child | Social Anxiety | Nursing Caries | Disabling Disease | Animal CommunicationTurkey
-
Universitair Ziekenhuis BrusselCompletedHospitalization in ChildrenBelgium
-
Daniel Collado-MateoAsociación Dame La PataRecruitingWork Related Stress | Occupational GroupsSpain
-
Daniel Collado-MateoPurina España (Reg. Trademark of Nestle S.A.)Enrolling by invitationEating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/BulimiaSpain
-
Daniel Collado-MateoAsociación de Padres de Personas Con Autismo (APNA); Asociación Nuevo Horizonte and other collaboratorsEnrolling by invitationAutism Spectrum Disorder | AutismSpain